Dzau Vj
About
In The Last Decade
Dzau Vj
15 papers receiving 291 citations
Peers
Comparison fields: 5 of 59
- Cardiology and Cardiovascular Medicine 174
- Molecular Biology 118
- Endocrinology, Diabetes and Metabolism 74
- Surgery 43
- Pathology and Forensic Medicine 32
Countries citing papers authored by Dzau Vj
This map shows the geographic impact of Dzau Vj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dzau Vj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dzau Vj more than expected).
Fields of papers citing papers by Dzau Vj
This network shows the impact of papers produced by Dzau Vj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dzau Vj. The network helps show where Dzau Vj may publish in the future.
Co-authorship network of co-authors of Dzau Vj
This figure shows the co-authorship network connecting the top 25 collaborators of Dzau Vj. A scholar is included among the top collaborators of Dzau Vj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dzau Vj. Dzau Vj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The concept and potentials of cardiovascular gene therapy. | 6 |
| 2 | Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides. | 12 |
| 3 | IN-VIVO GENE-THERAPY OF ANTI-THY-1 NEPHRITIS USING E2F DECOY OLIGONUCLEOTIDE | 9 |
| 4 | Molecular biology of angiotensin II biosynthesis and receptors. | 20 |
| 5 | Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy. | 9 |
| 6 | Tissue-Specificity of Renin Promoter Activity in the Mouse | 1 |
| 7 | Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control. | 25 |
| 8 | Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction. | 34 |
| 9 | Renin-angiotensin system and renal circulation in clinical congestive heart failure. | 20 |
| 10 | Evidence for the existence of renin in the heart. | 96 |
| 11 | Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis. | 17 |
| 12 | Hybridization studies with a renin cDNA probe: evidence for widespread expression of renin in the mouse. | 8 |
| 13 | Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats. | 50 |
| 14 | Effect of vinblastine on rat liver ultrastructure. | 2 |
| 15 | Effect of vinblastine on neurohypophysial and adenohypophysial microtubules. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.